Shapely Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.4/10
Best for: semaglutide at $99/month, 48% below the typical price
Shapely's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Charged on top
Coaching
In the price
Prices checked August 2026
Paying yourself, compounded semaglutide runs from $99/month and compounded tirzepatide from $166/month, supplies included, 2-day shipping free, and 503A/503B pharmacies licensed by the state doing the filling. Medicare and major PPO insurance are taken for the brand-name drugs, which include Mounjaro, Zepbound, Ozempic and Wegovy. The founder, Dr. Justin Zaghi, MD/MBA, trained at Harvard and holds board certification in obesity medicine as well as internal medicine.
Is Shapely legit?
Yes. Shapely is a real, operating US company, and we found no FDA warning letters issued to it. It says its medication comes from accredited compounding pharmacies (503A, 503B or PCAB). We rate it 8.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Shapely promo or coupon code?
We know of no promo or coupon code for Shapely. Its listed price is $99 a month. Coupon sites advertising "Shapely discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Shapely compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Shapely
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Shapely at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 4 states
- FDA status
- No FDA warning letters found
How Shapely scores
Six columns, each one computed from something Shapely has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
9.5/10$99/month is 46% below the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
7.5/10A price is shown before the questionnaire starts. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
2.6/10Serves 4 of 50 states.
Support10%
8.5/10The price covers the medication, clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Shapely
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: 4 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Shapely
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Shapely involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Shapely shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask Shapely which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $99, tirzepatide $166. That leaves out membership fees, first-month rates and insurance copays.
- Shapely serves 4 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Shapely
- Phone
- 424-600-8360
- Shapely offers email support
GLP-1 medications Shapely offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Starting at $99/month for a 3-month starter supply at the lowest dose ($297/quarter); ~$139/mo at low-mid doses, ~$179/mo at high doses. Free 2-day shipping; syringes and alcohol pads included. Filled by a state-licensed 503A/503B compounding pharmacy. A separate telehealth plan ($99/mo, $49 first-month promo) is required on top of the medication.
Starting at $166/month at the lowest starter dose; ~$249/mo at low-mid doses, ~$299/mo at high doses. Free 2-day shipping; syringes and alcohol pads included. Filled by a state-licensed 503A/503B compounding pharmacy. Self-pay only. A separate telehealth plan ($99/mo, $49 first-month promo) is required on top of the medication.
Check the price yourself before you pay
Every figure here was read off Shapely's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $99 a month, 46% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $166 a month, 34% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- We found no FDA warning letters issued to Shapely
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- Not included in the monthly price: lab work
- Serves only 4 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Shapely charges
Shapely lists $99/month. That sits at the affordable end of what we see.
- Compounded semaglutide: $99/month
- Compounded tirzepatide: $166/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Shapely's $99 is genuinely below the middle, not just advertised that way.
bmiMD, at about $99/month, is the closest like-for-like alternative we review.
What Shapely dispenses
Shapely prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
Safety and disclosure
Shapely tells you its price before you start the medical questionnaire, the 4 states it serves, and that its pharmacy is accredited. It also offers coaching as part of the plan. We found no FDA warning letters issued to Shapely. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Shapely will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want coaching bundled in rather than billed on top
- you want to try routing the cost through your insurance
Our read
Shapely competes on price without an obvious sacrifice elsewhere: $99/month, no FDA warning letters.
The Bottom Line
Shapely's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Shapely
Starting at $99 a month. Check today's price, then start the intake.
Where Shapely is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If your state is outside the area this one covers, consider Trimi Health.
Compare Shapely head to head
The sellers closest to Shapely on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Shapely review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Shapely's current pricing
Plans start at $99 a month. Whether you qualify is a clinician's decision, made after your intake.